| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0005 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |